Pfizer’s COVID-19 vaccine (Comirnaty) was 93% effective among adolescents at preventing hospitalization, even during the Delta surge, researchers found.
Among 179 patients ages 12-18 with COVID-19, 173 were unvaccinated, including 77 patients admitted to the ICU, 29 patients who were critically ill, and two that died, reported Samantha Olson, MPH, of the CDC, and colleagues, writing in an early edition of the Morbidity and Mortality Weekly Report.
Pfizer’s COVID-19 vaccine was highly effective among adolescents ages 12-15, showing 100% efficacy against symptomatic disease, which helped spur an amendment to the FDA emergency use authorization (EUA) in May. However, the authors noted that vaccine effectiveness data in real-world settings is “limited,” especially with regards to hospitalization in this population.
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
